Monograph

J01XE01 - Nitrofurantoin

Porphyrinogenic

Rationale

hydantoin derivative. Associated with attacks. Several references warn against it.

Chemical description

Nitrofuran derivative used in urinary tract infections. Between 30% and 50% of the dose is excreted in urine in unchanged form. No further data on metabolism or CYP interaction. Australian list: unsafe/attacks. South African list: use with extreme caution only. Tschudy, Lamon: 1980 potentially unsafe. Moore MR, Hift RJ 1997: potentially unsafe. Martindale: Considerd unsafe, associated with attacks.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes J01X / J01XE or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames